Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline

A multicenter prospective observational study

Kwang Jae Lee, Jin Il Kim, Ju Sang Park, Byung Sik Moon, Sang Gyun Kim, Jae Hee Chun, Hoon Yong Jung, Chang Hwan Choi, Seong Woo Chun, Geun Am Song, Myung Gyu Choi, Hoon-Jai Chun

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The objective of the study was to document practice pattern of gastroenterologists for the management of gastroesophageal reflux disease (GERD) under the minimal influence of the insurance reimbursement guideline. Data on management for 1,197 consecutive patients with typical GERD symptoms were prospectively collected during 16 weeks. In order to minimize the influence of reimbursement guideline on the use of proton pump inhibitors (PPIs), rabeprazole was used for the PPI treatment. A total of 861 patients (72%) underwent endoscopy before the start of treatment. PPIs were most commonly prescribed (87%). At the start of treatment, rabeprazole 20 mg daily was prescribed to 94% of the patients who received PPI treatment and 10 mg daily to the remaining 6%. At the third visits, rabeprazole 20 mg daily was prescribed to 70% of those who were followed and 10 mg daily for the remaining 30%. Continuous PPI treatment during the 16-week period was performed in 63% of the study patients. In conclusion, a full-dose PPI is preferred for the initial and maintenance treatment of GERD under the minimal influence of the insurance reimbursement guideline, which may reflect a high proportion of GERD patients requiring a long-term treatment of a full-dose PPI.

Original languageEnglish
Pages (from-to)1613-1618
Number of pages6
JournalJournal of Korean Medical Science
Volume26
Issue number12
DOIs
Publication statusPublished - 2011 Dec 1

Fingerprint

Proton Pump Inhibitors
Gastroesophageal Reflux
Insurance
Observational Studies
Prospective Studies
Guidelines
Rabeprazole
Therapeutics
Gastroenterologists
Endoscopy

Keywords

  • Gastroesophageal reflux disease
  • Korea
  • Proton pump inhibitors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline : A multicenter prospective observational study. / Lee, Kwang Jae; Kim, Jin Il; Park, Ju Sang; Moon, Byung Sik; Kim, Sang Gyun; Chun, Jae Hee; Jung, Hoon Yong; Choi, Chang Hwan; Chun, Seong Woo; Song, Geun Am; Choi, Myung Gyu; Chun, Hoon-Jai.

In: Journal of Korean Medical Science, Vol. 26, No. 12, 01.12.2011, p. 1613-1618.

Research output: Contribution to journalArticle

Lee, Kwang Jae ; Kim, Jin Il ; Park, Ju Sang ; Moon, Byung Sik ; Kim, Sang Gyun ; Chun, Jae Hee ; Jung, Hoon Yong ; Choi, Chang Hwan ; Chun, Seong Woo ; Song, Geun Am ; Choi, Myung Gyu ; Chun, Hoon-Jai. / Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline : A multicenter prospective observational study. In: Journal of Korean Medical Science. 2011 ; Vol. 26, No. 12. pp. 1613-1618.
@article{4845dbe5a97741a8af23dbf638aad395,
title = "Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: A multicenter prospective observational study",
abstract = "The objective of the study was to document practice pattern of gastroenterologists for the management of gastroesophageal reflux disease (GERD) under the minimal influence of the insurance reimbursement guideline. Data on management for 1,197 consecutive patients with typical GERD symptoms were prospectively collected during 16 weeks. In order to minimize the influence of reimbursement guideline on the use of proton pump inhibitors (PPIs), rabeprazole was used for the PPI treatment. A total of 861 patients (72{\%}) underwent endoscopy before the start of treatment. PPIs were most commonly prescribed (87{\%}). At the start of treatment, rabeprazole 20 mg daily was prescribed to 94{\%} of the patients who received PPI treatment and 10 mg daily to the remaining 6{\%}. At the third visits, rabeprazole 20 mg daily was prescribed to 70{\%} of those who were followed and 10 mg daily for the remaining 30{\%}. Continuous PPI treatment during the 16-week period was performed in 63{\%} of the study patients. In conclusion, a full-dose PPI is preferred for the initial and maintenance treatment of GERD under the minimal influence of the insurance reimbursement guideline, which may reflect a high proportion of GERD patients requiring a long-term treatment of a full-dose PPI.",
keywords = "Gastroesophageal reflux disease, Korea, Proton pump inhibitors",
author = "Lee, {Kwang Jae} and Kim, {Jin Il} and Park, {Ju Sang} and Moon, {Byung Sik} and Kim, {Sang Gyun} and Chun, {Jae Hee} and Jung, {Hoon Yong} and Choi, {Chang Hwan} and Chun, {Seong Woo} and Song, {Geun Am} and Choi, {Myung Gyu} and Hoon-Jai Chun",
year = "2011",
month = "12",
day = "1",
doi = "10.3346/jkms.2011.26.12.1613",
language = "English",
volume = "26",
pages = "1613--1618",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "12",

}

TY - JOUR

T1 - Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline

T2 - A multicenter prospective observational study

AU - Lee, Kwang Jae

AU - Kim, Jin Il

AU - Park, Ju Sang

AU - Moon, Byung Sik

AU - Kim, Sang Gyun

AU - Chun, Jae Hee

AU - Jung, Hoon Yong

AU - Choi, Chang Hwan

AU - Chun, Seong Woo

AU - Song, Geun Am

AU - Choi, Myung Gyu

AU - Chun, Hoon-Jai

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The objective of the study was to document practice pattern of gastroenterologists for the management of gastroesophageal reflux disease (GERD) under the minimal influence of the insurance reimbursement guideline. Data on management for 1,197 consecutive patients with typical GERD symptoms were prospectively collected during 16 weeks. In order to minimize the influence of reimbursement guideline on the use of proton pump inhibitors (PPIs), rabeprazole was used for the PPI treatment. A total of 861 patients (72%) underwent endoscopy before the start of treatment. PPIs were most commonly prescribed (87%). At the start of treatment, rabeprazole 20 mg daily was prescribed to 94% of the patients who received PPI treatment and 10 mg daily to the remaining 6%. At the third visits, rabeprazole 20 mg daily was prescribed to 70% of those who were followed and 10 mg daily for the remaining 30%. Continuous PPI treatment during the 16-week period was performed in 63% of the study patients. In conclusion, a full-dose PPI is preferred for the initial and maintenance treatment of GERD under the minimal influence of the insurance reimbursement guideline, which may reflect a high proportion of GERD patients requiring a long-term treatment of a full-dose PPI.

AB - The objective of the study was to document practice pattern of gastroenterologists for the management of gastroesophageal reflux disease (GERD) under the minimal influence of the insurance reimbursement guideline. Data on management for 1,197 consecutive patients with typical GERD symptoms were prospectively collected during 16 weeks. In order to minimize the influence of reimbursement guideline on the use of proton pump inhibitors (PPIs), rabeprazole was used for the PPI treatment. A total of 861 patients (72%) underwent endoscopy before the start of treatment. PPIs were most commonly prescribed (87%). At the start of treatment, rabeprazole 20 mg daily was prescribed to 94% of the patients who received PPI treatment and 10 mg daily to the remaining 6%. At the third visits, rabeprazole 20 mg daily was prescribed to 70% of those who were followed and 10 mg daily for the remaining 30%. Continuous PPI treatment during the 16-week period was performed in 63% of the study patients. In conclusion, a full-dose PPI is preferred for the initial and maintenance treatment of GERD under the minimal influence of the insurance reimbursement guideline, which may reflect a high proportion of GERD patients requiring a long-term treatment of a full-dose PPI.

KW - Gastroesophageal reflux disease

KW - Korea

KW - Proton pump inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84863039489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863039489&partnerID=8YFLogxK

U2 - 10.3346/jkms.2011.26.12.1613

DO - 10.3346/jkms.2011.26.12.1613

M3 - Article

VL - 26

SP - 1613

EP - 1618

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 12

ER -